Nephrocare
Health Services Limited, Asia’s largest dialysis network under the brand
“NephroPlus” announced its Financial Results for first quarter ended 30th June
2026.
Commenting
on the Q1FY27 results, Mr. Vikram Vuppala – Chairman & MD said,
“Dialysis
services across the World are mostly delivered by Pure play dialysis networks.
In India, today, only 21% of the dialysis services market is served by Pure
play dialysis networks. 16 years ago, this number was zero. As the dialysis
industry is shifting from Unorganized to Organized, NephroPlus, as the market
leader in India stands to gain disproportionately due to its focus on clinical
quality, service excellence and patient centricity.
As
we all know, the dialysis market is growing fast due to the ever-increasing
burden of Diabetes and Hypertension and this additional lever of shift from
Unorganized to Organized will help NephroPlus expand across India including the
Tier 2/Tier 3 cities and beyond.
As
we continue to scale up in existing countries, we are also exploring entry into
new countries via strategic acquisitions or long-term partnerships with payors.
We will continue to invest in identifying and understanding new geographies
where we believe we can make massive impact on dialysis patients’ lives while
creating shareholder value in the long term.”
Mr
Rohit Singh, Group Chief Executive Officer said,
“Q1
FY27 was a quarter of strong financial performance and continued strategic
expansion for NephroPlus. Revenue grew 23.7% year-on-year to ₹282 crore, and
EBITDA grew 30.7% YoY to ₹65 crore. Guest volumes grew 13% YoY to 38,262, as we
crossed 10,30,000 treatments in the first quarter of this financial year. Our
network reached 550 operating clinics across 5 countries, with a significant
50-clinic milestone in the Philippines. NephroPlus continues to demonstrate
that it is a dialysis platform made in India for the world.
This
past quarter, we launched the NephroPlus International Dialysis Academy (NIDA),
an in-house training program based in India and the Philippines, to build a
robust pipeline of renal nurses qualified to work anywhere in the world. This
will enable us to efficiently staff our international dialysis clinics where
hiring renal nurses is a huge challenge. Also, we have undertaken initiatives
to increase fistula creation and reduce cross-infections, and have launched the
NephroPlus Dialysis Index, a composite health score designed to monitor
clinical outcomes at the patient level, which can be aggregated at the Clinic,
Cluster, Zone, and Country levels over the next few quarters. Overall, we
remain confident in our ability to grow profitably and efficiently while
delivering superior clinical quality across every market we serve.”
Mr.
Prashant Goenka, Chief Financial Officer added,
"Q1
FY27 reflects the strength of our India platform — operating profitably at some
of the lowest price points globally, a solid reflection of the underlying
efficiency of our model. This efficiency, combined with high barriers to entry
in dialysis care, gives us the confidence to scale into the higher price-point
international markets, while preserving margin discipline rather than chasing
growth at any cost.
Revenue
grew 23.7% year-on-year, while Adjusted EBITDA grew faster at 30.7% and
Adjusted PAT faster still at 41.7% — each line outpacing the one above it, a
clear signature of operating leverage as platform strength converts scale into
higher profitability and returns. Capital continues to be deployed with
discipline, keeping us on track for durable, long-term value creation"
Nephrocare
Health Services Limited is Asia’s largest dialysis network, owning and
operating 550 dialysis centres under the NephroPlus brand. The Company has a
strong and growing footprint across India, Nepal, the Philippines, Uzbekistan,
and Saudi Arabia, delivering standardized, high-quality dialysis through a
scalable and asset-light model.
Comments
Post a Comment